Allergy Prevalence in France and Skin Impact - Epidemiological Survey of a Representative Sample of French Adults.

allergies food allergy prevalence respiratory allergy skin allergy skin side effects

Journal

Clinical, cosmetic and investigational dermatology
ISSN: 1178-7015
Titre abrégé: Clin Cosmet Investig Dermatol
Pays: New Zealand
ID NLM: 101543449

Informations de publication

Date de publication:
2021
Historique:
received: 01 04 2021
accepted: 02 07 2021
entrez: 21 7 2021
pubmed: 22 7 2021
medline: 22 7 2021
Statut: epublish

Résumé

Increased allergy frequency may have a significant impact on the skin, one of the largest targeted organs for allergic and immunological responses. An online survey of 2036 adults as a representative sample of the French general population was conducted to evaluate the prevalence of self-reported allergies, the populations who report allergies and the skin conditions related to allergies. In general, 20.2% of French adults (average age 45 ± 15.8 years) reported allergies. These allergies were respiratory allergies (55.3%), skin allergies (48.8%) and food allergies (27.9%), and 78.9% indicated that their reported allergies were diagnosed by a doctor. In addition, 53.2% of individuals reporting an allergy also indicated that they experienced associated skin reactions. In comparison to those who did not report an allergy, these individuals were 1.5 to 4 times more likely to have a skin disease and 3 times more likely to have sensitive skin or skin reactions when using skincare products. It is estimated that over 10 million French adults have allergies. These data will help increase awareness among the allergic population and healthcare professionals about the burden associated with allergies and the need for management to reduce their health impact.

Sections du résumé

BACKGROUND BACKGROUND
Increased allergy frequency may have a significant impact on the skin, one of the largest targeted organs for allergic and immunological responses.
METHODS METHODS
An online survey of 2036 adults as a representative sample of the French general population was conducted to evaluate the prevalence of self-reported allergies, the populations who report allergies and the skin conditions related to allergies.
RESULTS RESULTS
In general, 20.2% of French adults (average age 45 ± 15.8 years) reported allergies. These allergies were respiratory allergies (55.3%), skin allergies (48.8%) and food allergies (27.9%), and 78.9% indicated that their reported allergies were diagnosed by a doctor. In addition, 53.2% of individuals reporting an allergy also indicated that they experienced associated skin reactions. In comparison to those who did not report an allergy, these individuals were 1.5 to 4 times more likely to have a skin disease and 3 times more likely to have sensitive skin or skin reactions when using skincare products.
CONCLUSION CONCLUSIONS
It is estimated that over 10 million French adults have allergies. These data will help increase awareness among the allergic population and healthcare professionals about the burden associated with allergies and the need for management to reduce their health impact.

Identifiants

pubmed: 34285536
doi: 10.2147/CCID.S307345
pii: 307345
pmc: PMC8286784
doi:

Types de publication

Journal Article

Langues

eng

Pagination

901-907

Informations de copyright

© 2021 Seité et al.

Déclaration de conflit d'intérêts

S. Seité is an employee of La Roche-Posay, France. C. Taieb, Nhân Pham-Thi and A. Barbaud have served as consultants for L’Oreal/La Roche-Posay. The authors report no other conflicts of interest in this work.

Références

World Allergy Organ J. 2019 Oct 04;12(9):100057
pubmed: 31641405
J Allergy Clin Immunol Pract. 2013 Jan;1(1):22-8
pubmed: 24229818
Clin Exp Immunol. 2010 Apr;160(1):1-9
pubmed: 20415844
Dermatol Res Pract. 2019 Mar 3;2019:3797536
pubmed: 30941167
Environ Int. 2019 Apr;125:252-260
pubmed: 30731375
Clin Transl Allergy. 2019 Jan 24;9:3
pubmed: 30697418
J Eur Acad Dermatol Venereol. 2018 Jun;32(6):850-878
pubmed: 29878606
J Allergy Clin Immunol. 2019 Jan;143(1):378-385.e9
pubmed: 30336226
Pediatr Allergy Immunol. 2018 Sep;29(6):596-605
pubmed: 29624745
Pediatr Ann. 2013 Jul;42(7):141-5
pubmed: 23805962
NCHS Data Brief. 2013 May;(121):1-8
pubmed: 23742874
Clin Exp Allergy. 2019 Nov;49(11):1475-1486
pubmed: 31441980
Intern Med J. 2017 Mar;47(3):256-261
pubmed: 28260260
J Allergy Clin Immunol. 2011 Mar;127(3):594-602
pubmed: 21236480
Sci Total Environ. 2019 Sep 10;682:364-373
pubmed: 31125750
Pediatr Allergy Immunol. 2016 Aug;27(5):478-85
pubmed: 26842875
J Dermatol Sci. 2014 Dec;76(3):163-8
pubmed: 25278222
J Asthma. 1998;35(7):585-97
pubmed: 9777885
J Drugs Dermatol. 2019 Jun 01;18(6):581
pubmed: 31251552
Indian J Dermatol Venereol Leprol. 2017 Jul-Aug;83(4):415-423
pubmed: 28195077

Auteurs

Sophie Seité (S)

La Roche-Posay Dermatological Laboratories, Levallois-Perret, France.

Charles Taieb (C)

European Market Maintenance Assessment, Fontenay-sous-Bois, France.

Nhân Pham-Thi (N)

Ecole Polytechnique, Economics, Palaiseau, France.
Institut Pasteur Paris, Allergology, Paris, France.

Annick Barbaud (A)

Dermatology and Allergy Department, Tenon Hospital, Medicine Sorbonne University, Paris, France.
Assistance Publique-Hôpitaux de Paris, Paris, France.

Classifications MeSH